Pure Biologics webinar - year summary and project updates

Webinar with the management.

12 January

2021

PB012 PureApta on the NCBR beneficiaries’ list of successes

The National Center for Research and Development placed the project on the list of beneficiaries' successes.

8 January

2021

The research is carried out by Timeline Bioresearch, experienced in immuno-oncology and intestinal cancer models.

16 December

2020

News on the debut of Pure Biologics on the WSE Main Market in key business and industry media.

11 December

2020

Pure Biologics debut on the Regulated Market of the Warsaw Stock Exchange.

25 November

2020

The guest of Grzegorz Siemionczyk's #PROSTOzPARKIET program was Filip Jeleń, CEO of Pure Biologics.

9 October

2020

17 June

2020

10 April

2020

25 January

2020

21 January

2020